Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Clinical Pharmacology and Therapeutics
|
November 13, 2004
St John's wort, depression, and catecholamines
Christine A Haller
Clinical Toxicology (Philadelphia, Pa.)
|
August 15, 2006
Clinical approach to adverse events and interactions related to herbal and dietary supplements
Christine A Haller
The American Journal of Medicine
|
September 17, 2005
Hemodynamic effects of ephedra-free weight-loss supplements in humans
Christine A Haller, Neal L Benowitz, Peyton Jacob
Clinical Pharmacology and Therapeutics
|
April 3, 2004
Enhanced stimulant and metabolic effects of combined ephedrine and caffeine
Christine A Haller, Peyton Jacob, Neal L Benowitz
Clinical Pharmacology and Therapeutics
|
June 28, 2002
Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use
Christine A Haller, Peyton Jacob, Neal L Benowitz
Clinical Pharmacology and Therapeutics
|
June 18, 2005
Short-term metabolic and hemodynamic effects of ephedra and guarana combinations
Christine A Haller, Peyton Jacob, Neal L Benowitz
British Journal of Clinical Pharmacology
|
March 18, 2008
Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions
Christine A Haller, Minjing Duan, Peyton Jacob, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
March 1, 2005
Seizures reported in association with use of dietary supplements
Christine A Haller, Kathryn H Meier, Kent R Olson
Journal of Analytical Toxicology
|
April 27, 2004
Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements
Christine A Haller, Minjing Duan, Neal L Benowitz, et al.
The Western Journal of Medicine
|
January 15, 2002
Making a diagnosis of herbal-related toxic hepatitis
Christine A Haller, Jo Ellen Dyer, Richard Ko, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Clinical Pharmacology and Therapeutics
|
November 13, 2004
St John's wort, depression, and catecholamines
Christine A Haller
Clinical Toxicology (Philadelphia, Pa.)
|
August 15, 2006
Clinical approach to adverse events and interactions related to herbal and dietary supplements
Christine A Haller
The American Journal of Medicine
|
September 17, 2005
Hemodynamic effects of ephedra-free weight-loss supplements in humans
Christine A Haller, Neal L Benowitz, Peyton Jacob
Clinical Pharmacology and Therapeutics
|
April 3, 2004
Enhanced stimulant and metabolic effects of combined ephedrine and caffeine
Christine A Haller, Peyton Jacob, Neal L Benowitz
Clinical Pharmacology and Therapeutics
|
June 28, 2002
Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use
Christine A Haller, Peyton Jacob, Neal L Benowitz
Clinical Pharmacology and Therapeutics
|
June 18, 2005
Short-term metabolic and hemodynamic effects of ephedra and guarana combinations
Christine A Haller, Peyton Jacob, Neal L Benowitz
British Journal of Clinical Pharmacology
|
March 18, 2008
Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions
Christine A Haller, Minjing Duan, Peyton Jacob, et al.
Clinical Toxicology (Philadelphia, Pa.)
|
March 1, 2005
Seizures reported in association with use of dietary supplements
Christine A Haller, Kathryn H Meier, Kent R Olson
Journal of Analytical Toxicology
|
April 27, 2004
Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements
Christine A Haller, Minjing Duan, Neal L Benowitz, et al.
The Western Journal of Medicine
|
January 15, 2002
Making a diagnosis of herbal-related toxic hepatitis
Christine A Haller, Jo Ellen Dyer, Richard Ko, et al.
Page
of 2